{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:46:40Z","timestamp":1765828000844,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.rbmo.2021.01.017","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T07:17:40Z","timestamp":1611991060000},"page":"694-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exogenous progesterone for LH surge prevention is redundant in ovarian stimulation protocols"],"prefix":"10.1016","volume":"42","author":[{"given":"Ioannis E.","family":"Messinis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina I.","family":"Messini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Anifandis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Daponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rbmo.2021.01.017_bib0001","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.rbmo.2020.01.027","article-title":"Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis","volume":"40","author":"Alexandru","year":"2020","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2021.01.017_bib0002","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.rbmo.2021.01.017_bib0003","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rbmo.2020.05.001","article-title":"COVID-19 and fertility: a virtual reality","volume":"41","author":"Anifandis","year":"2020","journal-title":"Reprod. BioMed. Online."},{"issue":"5","key":"10.1016\/j.rbmo.2021.01.017_bib0004","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Beguer\u00eda","year":"2019","journal-title":"Hum. Reprod."},{"issue":"12","key":"10.1016\/j.rbmo.2021.01.017_bib0005","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/humrep\/dez233","article-title":"Should we still perform fresh embryo transfers in ART?","volume":"34","author":"Blockeel","year":"2019","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.rbmo.2021.01.017_bib0006","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/humrep\/deh415","article-title":"Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study","volume":"19","author":"Dal Prato","year":"2004","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.rbmo.2021.01.017_bib0007","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2019.12.024","article-title":"Progesterone is a physiological trigger of ovulatory gonadotropins","volume":"113","author":"Dozortsev","year":"2020","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.rbmo.2021.01.017_bib0008","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.fertnstert.2005.08.048","article-title":"Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol","volume":"85","author":"Griesinger","year":"2006","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.rbmo.2021.01.017_bib0009","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.rbmo.2021.01.017_bib0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","article-title":"New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology","volume":"298","author":"Iwami","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"11","key":"10.1016\/j.rbmo.2021.01.017_bib0011","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/humrep\/15.11.2333","article-title":"Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study","volume":"15","author":"Janssens","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2021.01.017_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7827-10-35","article-title":"Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort","volume":"10","author":"Kato","year":"2012","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"6","key":"10.1016\/j.rbmo.2021.01.017_bib0013","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.rbmo.2021.01.017_bib0014","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.rbmo.2021.01.017_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"La Marca","year":"2019","journal-title":"Reprod. Biomed. Online"},{"issue":"9","key":"10.1016\/j.rbmo.2021.01.017_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fendo.2018.00033","article-title":"Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation-A Retrospective Proof-of-Concept Study","volume":"9","author":"Lawrenz","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.rbmo.2021.01.017_bib0017","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/deg066","article-title":"Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation","volume":"18","author":"Loumaye","year":"2003","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.rbmo.2021.01.017_bib0018","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/jcem-49-4-507","article-title":"Roles of estradiol and progesterone in eliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges","volume":"49","author":"March","year":"1979","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.rbmo.2021.01.017_bib0019","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rbmo.2020.01.016","article-title":"Does LH suppression by progesterone-primed ovarian stimulation compared with GnRH antagonist affect live birth rate among oocyte recipients?","volume":"40","author":"Mart\u00ednez","year":"2020","journal-title":"Reprod. Biomed. Online"},{"issue":"5","key":"10.1016\/j.rbmo.2021.01.017_bib0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humupd\/dml020","article-title":"Ovarian feedback, mechanism of action and possible clinical implications","volume":"12","author":"Messinis","year":"2006","journal-title":"Hum. Reprod. Update"},{"issue":"6","key":"10.1016\/j.rbmo.2021.01.017_bib0021","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2265.1986.tb03618.x","article-title":"The effect of pulsatile follicle stimulating hormone on the endogenous luteinizing hormone surge in women","volume":"25","author":"Messinis","year":"1986","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.rbmo.2021.01.017_bib0022","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.humrep.a136481","article-title":"Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone","volume":"2","author":"Messinis","year":"1987","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.rbmo.2021.01.017_bib0023","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2265.1986.tb01705.x","article-title":"Relationships between the characteristics of endogenous luteinizing hormone surge and the degree of ovarian hyperstimulation during superovulation induction in women","volume":"25","author":"Messinis","year":"1986","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"11","key":"10.1016\/j.rbmo.2021.01.017_bib0024","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dei210","article-title":"Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment","volume":"20","author":"Messinis","year":"2005","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.rbmo.2021.01.017_bib0025","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.fertnstert.2009.12.055","article-title":"Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women","volume":"94","author":"Messinis","year":"2010","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.rbmo.2021.01.017_bib0026","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0015-0282(16)53231-2","article-title":"Role of the amplitude of the gonadotropin surge in the rat","volume":"53","author":"Peluso","year":"1990","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.rbmo.2021.01.017_bib0027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/humupd\/dmt014","article-title":"Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles","volume":"19","author":"Venetis","year":"2013","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.rbmo.2021.01.017_bib0028","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10815-020-01755-0","article-title":"Impact of progestin ovarian stimulation on newborn outcomes: a meta-analysis","volume":"37","author":"Zolfaroli","year":"2020","journal-title":"J. Assist. Reprod. Genet."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648321000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648321000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:20:09Z","timestamp":1761466809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648321000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1472648321000481"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2021.01.017","relation":{},"ISSN":["1472-6483"],"issn-type":[{"type":"print","value":"1472-6483"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous progesterone for LH surge prevention is redundant in ovarian stimulation protocols","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2021.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}]}}